Pediatrics|Treatment|Breakthrough · July 13, 2026
FDA Accepts Application for Full Approval of Achondroplasia Drug Voxzogoe
FDA acceptance of BioMarin's supplemental application brings expanded treatment options for children with skeletal dysplasia....
